SMOKE-DERIVED NITRIC-OXIDE AND VASCULAR PROSTACYCLIN ARE UNABLE TO COUNTERACT THE PLATELET EFFECT OF INCREASED THROMBOXANE FORMATION IN HEALTHY FEMALE SMOKERS
C. Rangemark et A. Wennmalm, SMOKE-DERIVED NITRIC-OXIDE AND VASCULAR PROSTACYCLIN ARE UNABLE TO COUNTERACT THE PLATELET EFFECT OF INCREASED THROMBOXANE FORMATION IN HEALTHY FEMALE SMOKERS, Clinical physiology, 16(3), 1996, pp. 301-315
The incidence of cigarette smoking tends to be higher in women, justif
ying directed studies on smoke-related mechanisms of cardiovascular di
sorder in females. Platelet activity plays an important etiological ro
le in several settings of cardiovascular disease. Cigarette smoking fa
cilitates platelet formation of proaggregatory thromboxane A(2), Howev
er, cigarette smoke contains nitric oxide (NO), which has antiplatelet
activity. Furthermore, the formation of anti-aggregatory prostacyclin
(PGI(2)) may be higher in smokers than in non-smokers. Hence, the con
certed action of NO and PGI(2) on platelet activity in smoking females
is important to elucidate. The metabolites of TxA(2), NO, and PGI(2),
as well as cyclic guanosine 3':5'-monophosphate (cGMP; second messeng
er for NO in the platelets) and cyclic adenosine 3':5'-monophosphate (
cAMP; second messenger for PGI(2) in the platelets), were analysed in
23 healthy female smokers (daily consumption 11-20 cigarettes per day)
and in 26 matched non-smokers. The urinary excretion of 2,3-dinor TxB
(2) (metabolite of TxA(2)) was considerably higher in smokers than in
non-smokers (177 vs. 72 pg/mg creatinine, respectively; P<0.001). Plas
ma and urinary levels of nitrate (metabolite of inhaled NO) did not di
ffer between the groups. Plasma and urinary cGMP were slightly increas
ed (252 vs. 193 nmol/L; P<0.05 and 0.63 vs. 0.51 mu mol/24 h; P<0.05,
respectively) in smokers compared to non-smokers, while platelet cGMP
was lower in smokers than in non-smokers (81 vs. 10.3 pmol/10(6) plate
lets, respectively; P<0.05). The urinary excretion of 2,3-dinor-6-keto
-PGF(1a) (metabolite of PGI(2)) did not differ between the groups. Pla
telet or urinary cAMP did not differ between the groups either, while
plasma cAMP was lower in smokers than in non-smokers (19.2 vs. 26.2 nm
ol/l, respectively; P<0.001). In healthy female smokers NO is not abso
rbed from the inhaled smoke, and endothelial PGI(2) formation is not e
nhanced to counterbalance the increased platelet formation of proaggre
gatory TxA(2).